Plain-English translation of NCT04321512 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers are studying special immune cells called monocytes in people who have recently experienced a heart attack or stroke. By measuring these cells at different times after the event, scientists hope to better understand how the body responds to these emergencies and identify patterns that could help predict recovery or complications.
When a heart attack or stroke happens, the body's immune system responds in specific ways. This study exists to map out those responses so doctors can eventually use this information to better predict which patients might be at higher risk for serious complications and improve treatment decisions.
You likely qualify if…
You likely don't qualify if…
If you join this study, you would donate blood samples at specific time points: within 48 hours of your hospital admission, again 2 to 14 days later, and once more 30 to 120 days after your heart attack or stroke. The research team will analyze these samples to measure immune cell levels and look for patterns that help explain how your body recovers from the event. The entire study takes about 4 months, and participants are also asked to allow researchers to review their medical records.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
United States
Enrollment target
~300 participants
Started
December 2013
Primary completion
December 2027
Age range
18 Years and older
Last updated on clinicaltrials.gov in August 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Fahad Shah, BSc.
UConn Health
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.